Testing effectiveness (Phase 2)Ended earlyNCT06137183
What this trial is testing
Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC)
Who this might be right for
Ulcerative Colitis
Genentech, Inc. 79